Sharda Cropchem LimitedQ2 FY27 Results & Financial Update
Sharda Cropchem Limited: Q2 FY27 consolidated results and company financials – revenue ₹1,051.68 Cr, PAT ₹91.73 Cr. Explore reported YoY/QoQ movements, margins, business drivers and management commentary. This page does not provide a rating, target price or investment recommendation.
Quarter at a glanceCurrent reported figures.Change figures appear when a comparable reported period is available.
Find an answer
Ask this result
Chart · Market context
Sharda Cropchem price & chart
Market price₹724.05
1Y return—Price return
Loading market chart…
TradingView Lightweight Charts™ · Copyright © 2025 TradingView, Inc.TradingView
Market chartPrice chart temporarily unavailableThe price chart could not be loaded right now. The reported financial results remain available above.
Spotted a factual error?Tell us the number, date or statement and we will re-check the underlying records and calculations.Report an error
Quarterly Results AnalysisExplore Sharda Cropchem Q2 FY27 quarterly results and earnings: revenue, profit (PAT), EBITDA, margins, YoY and QoQ growth, order book or business updates where reported, financial performance and management commentary. Reported figures and Nivata calculations are shown separately; no buy, sell or hold recommendation is provided.
Quarter overview
Quarterly earnings analysis
Sharda Cropchem Limited reported consolidated revenue from operations of Rs. 1,051.68 crore for the quarter ended September 30, 2026, representing a marginal sequential moderation of 2.06% compared to Rs. 1,073.77 crore in Q1 FY27, while expanding by 13% year-on-year according to company presentation disclosures.
Profit before tax (PBT) for Q2 FY27 was recorded at Rs. 107.49 crore, compared to Rs. 118.43 crore in the preceding quarter.
Net profit (PAT) for the quarter improved sequentially by 4.22% to Rs. 91.73 crore from Rs. 88.02 crore in Q1 FY27, reflecting effective tax management during the period.
Total tax expense for the quarter decreased substantially to Rs. 15.76 crore compared to Rs. 30.41 crore in the June 2026 quarter, lifting the PAT margin from 8.20% to 8.72%.
Basic and diluted earnings per share (EPS) for the quarter stood at Rs. 10.17 each, compared to Rs. 9.76 in the previous quarter.
01 · Business model
What does Sharda Cropchem do?
Sharda Cropchem Limited operates as an intellectual property (IP)-driven global agrochemical and specialty chemical enterprise, focusing on the marketing and distribution of generic crop protection formulations and active ingredients.
The business model is asset-light and registration-led, bypassing heavy manufacturing investments in basic and applied research and active ingredient production by partnering with specialized manufacturers, while retaining full control over product registrations, dossiers, and customer relationships.
The product portfolio spans herbicides, fungicides, insecticides, and biocides within the agrochemical segment, alongside non-agrochemical offerings including rubber and conveyor belts, dyes and dye intermediates, and industrial chemicals.
Reaching customers across more than 80 countries, the company leverages a global network backed by over 525 third-party distributors and a dedicated sales force of more than 500 professionals.
02 · Historical context
What shaped the business before this quarter
Historically, Sharda Cropchem has built its core competitive moat on an extensive, scalable library of dossiers and product registrations secured ahead of market opportunities across regulated jurisdictions.
03 · Financial snapshot
Current quarter vs the available comparable
| Metric | Q2 FY27 | Previous quarter |
|---|---|---|
| Revenue from operations | ₹1,051.68 Cr | ₹1,073.77 Cr |
| Total income | ₹1,096.31 Cr | ₹1,108.29 Cr |
| Profit before tax | ₹107.49 Cr | ₹118.43 Cr |
| Profit after tax | ₹91.73 Cr | ₹88.02 Cr |
| EPS | ₹10.17 | ₹9.76 |
Financial interpretation
What the reported numbers mean
Profit after tax represented 8.7% of reported quarterly operating revenue. This is a calculated net-profit-to-sales ratio, not a company-reported operating margin. It measures the outcome after expenses and tax; it does not, by itself, establish how margins changed versus another period.
Profit before tax was equivalent to 10.2% of quarterly operating revenue. The distinction between pre-tax and post-tax profit matters when interpreting earnings; neither ratio identifies an underlying cost driver without a properly matched comparative period.
Total income exceeded operating revenue by ₹44.63 crore. This is the disclosed difference between the two lines, not incremental sales. The distinction matters when assessing how much of the quarter’s reported income came from the operating top line.
Ratios above are calculated from the reported quarterly figures. They are analytical descriptions, not company-reported margin guidance or an investment recommendation.
04 · Why it moved
Why the quarter looked the way it did
What drove revenue
Agrochemical revenue for Q2 FY27 stood at Rs. 839.73 crore (Rs. 840 crore in investor disclosures), compared to Rs. 914.86 crore in Q1 FY27 and Rs. 802.74 crore in Q2 FY25.
Non-agrochemical revenue, encompassing belts, dyes, and industrial chemicals, contributed Rs. 211.96 crore (Rs. 212 crore in investor disclosures) in Q2 FY27, marking an increase from Rs. 158.91 crore in Q1 FY27 and Rs. 126.37 crore in Q2 FY25.
Agrochemical sales across regions showed Europe at Rs. 429 crore, NAFTA at Rs. 227 crore, LATAM at Rs. 128 crore, and Rest of World (ROW) at Rs. 55 crore.
What drove margins
Cost of materials consumed was Rs. 268.27 crore, while purchases of stock-in-trade stood at Rs. 449.68 crore, offset by inventory changes of Rs. (170.16) crore.
05 · Segments, products & geography
Which parts of the business are doing the work
Segments and products
The agrochemical segment remains highly seasonal in nature, with performance heavily influenced by global cropping patterns and weather conditions, making quarterly figures non-representative of full-year results.
Agrochemical segment results before finance costs and unallocable items were Rs. 68.85 crore, while non-agrochemical segment results contributed Rs. 37.36 crore.
06 · Reported developments
What changed operationally
Net profit grew by 4.22% sequentially despite a minor dip in total revenue, aided by a lower tax burden and fair valuation gains on investments.
07 · Items worth noticing
The line items that can distort a quick read
Other expenses/income for the quarter included a gain of Rs. 240.07 lakhs (Rs. 2.40 crore) on the fair valuation of current investments.
08 · Cash flow & balance sheet
Profit is one thing. Cash and funding tell another part of the story.
Investor disclosures highlight that working capital days improved from 98 days as of March 2026 to 70 days as of September 2026, driven by optimized inventory and receivables management.
09 · Beyond the numbers
What changed beyond the numbers
Reported update
Subsidiary Network
As of September 30, 2026, the company maintains a global network of 36 subsidiaries, which includes 8 step-down subsidiaries.
10 · Previous-quarter changes
What changed since the previous quarter
Revenue from operations contracted by 2.06% from Rs. 1,073.77 crore in Q1 FY27 to Rs. 1,051.68 crore in Q2 FY27.
11 · Key Q&A
The quarter, answered directly
What does Sharda Cropchem do?
Sharda Cropchem Limited operates as an intellectual property (IP)-driven global agrochemical and specialty chemical enterprise, focusing on the marketing and distribution of generic crop protection formulations and active ingredients.
What is the clearest takeaway from Q2 FY27?
Sharda Cropchem Limited reported consolidated revenue from operations of Rs. 1,051.68 crore for the quarter ended September 30, 2026, representing a marginal sequential moderation of 2.06% compared to Rs. 1,073.77 crore in Q1 FY27, while expanding by 13% year-on-year according to company presentation disclosures.
What drove revenue or demand?
Agrochemical revenue for Q2 FY27 stood at Rs. 839.73 crore (Rs. 840 crore in investor disclosures), compared to Rs. 914.86 crore in Q1 FY27 and Rs. 802.74 crore in Q2 FY25.
What mattered most for margins or profitability?
Cost of materials consumed was Rs. 268.27 crore, while purchases of stock-in-trade stood at Rs. 449.68 crore, offset by inventory changes of Rs. (170.16) crore.
What changed operationally beyond the headline numbers?
As of September 30, 2026, the company maintains a global network of 36 subsidiaries, which includes 8 step-down subsidiaries.
What should the next disclosure help confirm?
Monitor upcoming seasonal cropping cycles and weather patterns across Europe and Latin America that dictate agrochemical demand.
12 · Scenario calculator
Earnings sensitivity: what if growth and margins change?
Starting point
Build your own next-quarter scenario
Reported values are prefilled where a comparable basis is available. Otherwise, the field starts at 0. You can overwrite every field.
Example: enter 10 for 10% revenue growth. Enter -100 for a 1 percentage-point margin decline.
Scenario output
Scenario revenue / income₹0 cr
Scenario profit after tax₹0 cr
Profit change vs base₹0 cr (0%)
Scenario margin0%
Growth needed to keep profit flat after this margin move0%
The calculator holds the selected margin basis constant except for the basis-point adjustment you enter. It does not estimate tax, finance cost, dilution, working capital, valuation or share price.
13 · Next filing checkpoints
What the next disclosure can confirm or change
- 01
Global Agrochemical Demand: Monitor upcoming seasonal cropping cycles and weather patterns across Europe and Latin America that dictate agrochemical demand.
- 02
Working Capital Efficiency: Track whether the reduction in working capital cycle days to 70 days is sustained through the second half of FY27.
Learn the metrics
Need the concepts first?
Use Nivata’s plain-English guides to understand the accounting terms used in this brief before interpreting them.